Harmony Biosciences Reports First Quarter 2021 Results and Business Updates
WAKIX® (pitolisant) Total Revenue of $59.7 Million for First Quarter 2021 Achieves Profitability with $7.4 Million Net Income Conference Call...
Month: May 2021
Protech Home Medical Announces Intention to Change Name and Consolidate Stock in Anticipation of Proposed NASDAQ Listing
Protech Home Medical to Change Name to Quipt Home Medical, a Burgeoning Leader in At Home Respiratory Care Expanding Rapidly...
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2021 Financial Results
Expands pipeline with new indications for PRAX-114 and PRAX-944 PRAX-114 Phase 2 trial for treatment of post-traumatic stress disorder to...
Solid Biosciences to Host First Quarter 2021 Financial Results and Business Update Call on May 14, 2021
CAMBRIDGE, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing...
Odyssey Group International Welcomes Dr Bob Arnot to Scientific Advisory Board
Dr. Arnot joins an elite board assembled to aid the advancement of innovative technologies being developed to address brain injury...
Delcath Systems, Inc. Announces First Quarter 2021 Results
NEW YORK, May 11, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the...
Immunoscore® is now available in Rectal Cancer for expert clinical centers through an Innovation Access Program
Immunoscore® heads up to become the standard precision tool for the “Watch and Wait” strategy in locally advanced rectal cancerExpert...
VNA Signs Agreement to Sell Home Health and Hospice Services to Amedisys
OMAHA, Neb., May 11, 2021 (GLOBE NEWSWIRE) -- Visiting Nurse Association (VNA), a 125-year-old nonprofit that delivers quality home health...
Merus to Participate in a Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company...
Senti Bio to Present Data from CAR-NK Cell Oncology Pipeline at ASGCT 24th Annual Meeting
- Using Logic Gating gene circuits, Senti Bio is engineering allogeneic CAR-NK cells to target and more precisely eliminate cancer...
Treatment.com uses extensive consumer research to develop its healthcare app
VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment” or “The Company”) (CSE: TRUE) is an innovative...
Teladoc Health Launches “myStrength Complete” As First Unified Mental Health Care Experience
New Consumer Study Reinforces Impact of Comprehensive Virtual Mental Health Care myStrength Complete from Teladoc Health myStrength Complete from Teladoc...
Phathom Pharmaceuticals Reports First Quarter 2021 Results and Provides Recent Business Updates
Positive Phase 3 trial of vonoprazan in Helicobacter pylori (H. pylori) infection; New Drug Applications (NDAs) targeted for the fourth...
aTyr Pharma Announces Promotion of Leslie Nangle, Ph.D., to Vice President of Research
SAN DIEGO, May 11, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery...
New Preclinical Data Demonstrate Potential of Codiak’s Engineered Exosomes as Novel, Targeted Approaches in Multiple Disease Areas
Data at ASGCT 2021 show ability to design exosomes with specific features for immune evasion, tunable vaccine development, targeted cell...
Galecto Appoints Garrett Winslow as General Counsel
BOSTON, May 11, 2021 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a NASDAQ listed biotechnology company focused on the development...
CymaBay Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NEWARK, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing...
Acepodia Appoints Thorsten Graef, M.D., Ph.D., as Chief Medical Officer and Michael Brock as Chief Strategy Officer
Key executive hires strengthen Acepodia’s expanding leadership team and position the company for upcoming growth catalystsSAN MATEO, Calif., May 11,...
Allena Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
-- Enrollment ongoing in Phase 3 URIROX-2 clinical trial of reloxaliase; interim analysis expected 2Q or 3Q 2022 ---- Enrolling...
Medolife Rx Announces Changes in Management, Puts New Executive Leadership in Place
BURBANK, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company...